Parkinson's Archives

Libra Therapeutics, the virtual biotech company using data to boost CNS drug development

How a virtual company leveraged data to accelerate drug development for neurodegenerative diseases

Find out how the virtual biotech company Libra Therapeutics leveraged data to accelerate drug development for neurodegenerative diseases.

February 25, 2025 - 9 minutesmins - By External Contributor

In Depth 19 Sep 2024

Mitochondrial disease treatments: is a breakthrough on the horizon?

Mitochondrial dysfunction is linked to many diseases. Discover how biotechs are developing mitochondrial disease treatments to address these diseases.

September 19, 2024 - 8 minutesmins - By Roohi Mariam Peter

Best in Biotech 15 Aug 2024

10 neuroscience biotech companies you should know about

Learn more about nine of the top neuroscience biotech companies looking to develop treatments for difficult-to-treat neurological conditions.

August 15, 2024 - 12 minutesmins - By Willow Shah-Neville

News and Trends 14 Aug 2024

CAR-T drugs and parkinsonism: a cause for concern?

CAR-T therapies come with boxed warnings of serious neurotoxic side effects. Now, growing concerns over parkinsonism have led to a clinical trial halt.

August 14, 2024 - 3 minutesmins - By Roohi Mariam Peter

In Depth 4 Jul 2024

Parkinson’s disease: biotech’s pursuit for more therapies

Rigorous research aims to boost therapeutic options for people with Parkinson’s disease. What do biotechs have in store?

July 4, 2024 - 10 minutesmins - By Roohi Mariam Peter

Best in Biotech 30 May 2024

Stem cell therapy’s avant-garde: Eight companies leading the way

Stem cell therapy has gained traction over the recent years and the market is growing, discover eight companies advancing the field.

May 30, 2024 - 11 minutesmins - By Jules Adam

In Depth 19 Jan 2024

Re-coding the brain: Is CRISPR capable of curing neurodegenerative diseases?

Check out our latest article as we explore some of the latest research around using CRISPR technology to treat neurodegenerative diseases.

January 19, 2024 - 9 minutesmins - By Willow Shah-Neville

Podcast 15 Dec 2023

Vaxxinity making vaccines to change the world

Discover how Vaxxinity’s vaccine approach aims to democratize global health, potentially reshaping access to innovative treatments worldwide.

December 15, 2023

News and Trends 13 Jul 2023

Partnership to progress neurodegenerative disorder treatments

IRBM, Rainwater Charitable Foundation (RCF, Fort Worth, Texas), a private family foundation, and Weill Cornell Medicine (based in New York) are starting a multi-year drug discovery collaboration to identify small molecule cGAS (cyclic GMP-AMP synthase) inhibitors for the treatment of tauopathies and other neurodegenerative diseases. The collaboration brings together IRBM’s capabilities in drug discovery and […]

July 13, 2023 - 3 minutesmins - By Jim Cornall

News and Trends 11 Jul 2023

NodThera first to show reduction in neuroinflammation with inflammasome inhibitor

NodThera has announced positive, initial data from four subjects in the elderly volunteer stage of its phase Ib/IIa study evaluating the effects of its lead candidate NT-0796 on inflammatory and disease-specific biomarkers in the blood and cerebrospinal fluid (CSF). NodThera is a clinical-stage biotech developing brain-penetrant NLRP3 inflammasome inhibitors to treat chronic inflammatory diseases. Alan […]

July 11, 2023 - 3 minutesmins - By Jim Cornall

News and Trends 23 Jun 2023

SandboxAQ launches new division to boost drug development

After several years of stealth development, SandboxAQ has announced its bio-pharma molecular simulation division, AQBioSim, and some of its customers. The division is helping bio-pharma and research institutions achieve breakthroughs in treatments for cancer, Alzheimer’s, Parkinson’s, and other conditions. The company is currently working with biopharma companies and university research labs, including AstraZeneca, Sanofi and […]

June 23, 2023 - 3 minutesmins - By Jim Cornall

News and Trends 20 Jun 2023

NodThera announces positive inflammatory disease data

NodThera has announced positive data from first-in-human studies of its lead therapeutic candidates, NT-0249 and NT-0796. In the studies, both candidates were shown to clearly inhibit the NLRP3 inflammasome, a highly validated drug target that plays a pivotal role in controlling inflammatory diseases. The differentiated design characteristics of each candidate enabled them to penetrate different […]

June 20, 2023 - 3 minutesmins - By Jim Cornall

Resources

Categories

T cell engagers: A promising, fast-growing field for cancer and autoimmune disease treatments

The biggest biotech funding rounds in February 2025

Approaches

Therapeutic areas

Grab your free report on 3D organoids and explore their future potential

World Cancer Day: trends in cancer therapeutics to look forward to in 2025

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

T cell engagers: A promising, fast-growing field for cancer and autoimmune disease treatments

The biggest biotech funding rounds in February 2025

Grab your free report on 3D organoids and explore their future potential

World Cancer Day: trends in cancer therapeutics to look forward to in 2025

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Parkinson’s

How a virtual company leveraged data to accelerate drug development for neurodegenerative diseases

Mitochondrial disease treatments: is a breakthrough on the horizon?

10 neuroscience biotech companies you should know about

CAR-T drugs and parkinsonism: a cause for concern?

Parkinson’s disease: biotech’s pursuit for more therapies

Stem cell therapy’s avant-garde: Eight companies leading the way

Re-coding the brain: Is CRISPR capable of curing neurodegenerative diseases?

Vaxxinity making vaccines to change the world

Partnership to progress neurodegenerative disorder treatments

NodThera first to show reduction in neuroinflammation with inflammasome inhibitor

SandboxAQ launches new division to boost drug development

NodThera announces positive inflammatory disease data

Subscribe to our newsletter to get the latest biotech news!

T cell engagers: A promising, fast-growing field for cancer and autoimmune disease treatments

The biggest biotech funding rounds in February 2025

Grab your free report on 3D organoids and explore their future potential

World Cancer Day: trends in cancer therapeutics to look forward to in 2025

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

T cell engagers: A promising, fast-growing field for cancer and autoimmune disease treatments

The biggest biotech funding rounds in February 2025

Grab your free report on 3D organoids and explore their future potential

World Cancer Day: trends in cancer therapeutics to look forward to in 2025

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!